Tempus AI (NASDAQ:TEM) Stock Rating Upgraded by Wall Street Zen

Tempus AI (NASDAQ:TEM) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Saturday.

TEM has been the topic of several other reports. Mizuho initiated coverage on shares of Tempus AI in a research report on Thursday, February 19th. They issued an “outperform” rating and a $100.00 price objective on the stock. BTIG Research reissued a “buy” rating and issued a $80.00 price objective on shares of Tempus AI in a research report on Monday, June 1st. Morgan Stanley dropped their price objective on shares of Tempus AI from $85.00 to $70.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. Stifel Nicolaus set a $60.00 price objective on shares of Tempus AI in a research report on Wednesday, February 25th. Finally, Guggenheim dropped their price objective on shares of Tempus AI from $95.00 to $60.00 and set a “buy” rating on the stock in a research report on Monday, March 30th. Nine equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $68.64.

Tempus AI Stock Performance

NASDAQ TEM opened at $46.43 on Friday. The company has a current ratio of 3.31, a quick ratio of 3.15 and a debt-to-equity ratio of 2.96. The firm’s fifty day moving average price is $48.89 and its two-hundred day moving average price is $57.48. Tempus AI has a 1 year low of $41.73 and a 1 year high of $104.32. The firm has a market capitalization of $8.34 billion, a P/E ratio of -26.99 and a beta of 3.62.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings data on Tuesday, May 5th. The company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.21) by $0.08. The company had revenue of $348.12 million for the quarter, compared to analyst estimates of $345.44 million. Tempus AI had a negative net margin of 22.20% and a negative return on equity of 53.83%. The company’s revenue was up 36.1% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.24) earnings per share. As a group, research analysts anticipate that Tempus AI will post -1.35 EPS for the current year.

Insider Buying and Selling at Tempus AI

In related news, CFO James William Rogers sold 10,853 shares of the firm’s stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $44.07, for a total transaction of $478,291.71. Following the transaction, the chief financial officer directly owned 126,395 shares of the company’s stock, valued at approximately $5,570,227.65. This trade represents a 7.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Eric P. Lefkofsky sold 166,250 shares of the firm’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $46.70, for a total transaction of $7,763,875.00. Following the transaction, the chief executive officer directly owned 8,808,533 shares in the company, valued at approximately $411,358,491.10. This represents a 1.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 558,557 shares of company stock valued at $26,611,939 in the last quarter. Company insiders own 24.26% of the company’s stock.

Hedge Funds Weigh In On Tempus AI

A number of hedge funds have recently bought and sold shares of TEM. JPL Wealth Management LLC bought a new position in Tempus AI during the third quarter worth about $26,000. Los Angeles Capital Management LLC bought a new position in Tempus AI during the fourth quarter worth about $27,000. Harvest Fund Management Co. Ltd bought a new position in Tempus AI during the third quarter worth about $38,000. Whittier Trust Co. increased its position in Tempus AI by 190.0% during the first quarter. Whittier Trust Co. now owns 870 shares of the company’s stock worth $41,000 after acquiring an additional 570 shares during the period. Finally, Lodestone Wealth Management LLC bought a new position in Tempus AI during the fourth quarter worth about $42,000. 24.22% of the stock is owned by institutional investors.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.